New collaboration to improve the detection of type 2 diabetes in high-risk patients starts in Montreal, Quebec
The project will use artificial intelligence (A.I.), wearable...
Stress in healthcare workers: a model to help us rethink challenges
Better understand for better support: a new model developed by RI-MUHC researchers illustrates the relationships between the various factors...
Jesse Papenburg wins Principal’s Prize for sharing the science behind COVID-19
Leading McGill scholars celebrated for sharing their work with the media
COVID-19 vaccination highly effective in individuals with immune-related inflammatory diseases
RI-MUHC researcher Sasha Bernatsky is senior author of a nationwide study
$6.7 million to study the impacts of COVID-19 on children
Health Minister Jean-Yves Duclos visits Montreal to announce a new investment in pediatric research and to congratulate researcher...
Nadine Kronfli receives 2021 AMMI Canada New Investigator Award
RI-MUHC researcher confronts the unique challenges of eliminating infectious diseases in prisons
Benefits of fluvoxamine confirmed in new study
Preventing hospitalization following COVID-19 infection in vulnerable populations
Life-Threatening Illness National Group (LifTING) Research Training Platform funded
Congratulations to Dr. Patricia Fontela!
Michael S. Kramer awarded the Prix du chercheur émérite 2020-2021 by the RRSPQ
The RI-MUHC senior scientist will present a seminar on “Maternal and child population health...
TB and COVID-19, a joint battle?
On World TB Day 2022, we are looking at how researchers from the McGill International TB Centre at the RI-MUHC are working to raise awareness and to put an end to TB.